Company Overview of Mesoblast Limited
Jonathan Richard Symonds CBE, BA, FCA
Head of Corporate Finance & Strategy, Mesoblast Limited
|Age||Total Calculated Compensation||This person is connected to 5 Board Members in 5 different organizations across 12 different industries.|
See Board Relationships
55 Collins StreetPhone: 61 3 9639 6036
Melbourne, Victoria 3000
Fax: 61 3 9639 6030
Board Members Memberships
Independent Non-Executive Director, Chairman of Group Audit Committee and Member of Conduct & Values Committee
Chairman and Chairman of Chairman's Nominations & Remuneration Committee
Chairperson, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
University of Hertfordshire
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
Total CompensationThere is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Dominick C. Colangelo Esq.||Chief Executive Officer, President, Treasurer and Director|
|Gil Van Bokkelen Ph.D.||Co-Founder, Chairman and Chief Executive Officer|
|David A. Dresner||Interim Chief Executive Officer and Interim President|
Osiris Therapeutics, Inc.
|Christian Homsy M.D., MBA||Chief Executive Officer and Executive Director|
|$579.0K||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.